PhRMA Spends Record Lobbying Sum to Keep Drug Prices High
1 Articles
1 Articles
PhRMA Spends Record Lobbying Sum to Keep Drug Prices High
Share this post on X and Bluesky! In the first quarter of the year, Big Pharma’s top lobbying group spent a record-breaking $12.9 million on federal lobbying—an unprecedented blitz that coincided with a string of Trump administration decisions benefiting drugmakers. As the industry secured delays to drug price controls and other policy changes that will boost company profits, the Pharmaceutical Research & Manufacturers of America (PhRMA) was pay…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage